American Journal of Epidemiology Vol. 153, No. 1 : 27-29
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Invited Commentary: Studying the Epidemiology of Uterine Leiomyomata—Past, Present, and Future
1 Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
2 Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA.
Uterine leiomyomata have a substantial impact on women's reproductive health, but epidemiologists have focused relatively little energy on identifying risk factors for this condition. Only a handful of studies, most of which were not designed to address methodological challenges posed by these tumors, have been conducted. These studies focused almost exclusively on reproductive and hormonal characteristics as possible risk factors, but consistent relations have not emerged. Three new reports (from two studies) in this issue of the Journal target the paucity of information on uterine leiomyomata risk factors by testing novel hypotheses, by employing designs that incorporate subclinical tumors or account for variable management of clinically recognized disease, or by using a combination of these approaches. The success of these strategies and the contributions of the new findings are discussed. Recommendations are made for a program of research that eventually could improve our knowledge of uterine leiomyomata etiology and yield clues to the prevention of associated morbidity.
leiomyoma; uterine diseases
Abbreviations: UL, uterine leiomyomata
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in Am. J. Epidemiol.:
- Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. I. African-American Heritage, Reproductive History, Body Size, and Smoking
- Eduardo Faerstein, Moyses Szklo, and Neil Rosenshein
Am. J. Epidemiol. 2001 153: 1-10.[Abstract] [FREE Full Text] - Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. II. Atherogenic Risk Factors and Potential Sources of Uterine Irritation
- Eduardo Faerstein, Moyses Szklo, and Neil B. Rosenshein
Am. J. Epidemiol. 2001 153: 11-19.[Abstract] [FREE Full Text] - Risk Factors for Uterine Fibroids among Women Undergoing Tubal Sterilization
- Chao-Ru Chen, Germaine M. Buck, Norman G. Courey, Kimberly M. Perez, and Jean Wactawski-Wende
Am. J. Epidemiol. 2001 153: 20-26.[Abstract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  A.R.W. Williams, H.O.D. Critchley, J. Osei, S. Ingamells, I.T. Cameron, C. Han, and K. Chwalisz The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata Hum. Reprod., June 1, 2007; 22(6): 1696 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Baird, D. B. Dunson, M. C. Hill, D. Cousins, and J. M. Schectman Association of Physical Activity with Development of Uterine Leiomyoma Am. J. Epidemiol., January 15, 2007; 165(2): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Boynton-Jarrett, J. Rich-Edwards, S. Malspeis, S. A. Missmer, and R. Wright A Prospective Study of Hypertension and Risk of Uterine Leiomyomata Am. J. Epidemiol., April 1, 2005; 161(7): 628 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Klip, F. E. van Leeuwen, R. Schats, C.W. Burger, and for the OMEGA project group Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women Hum. Reprod., September 1, 2003; 18(9): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-R. Chen, G. M. Buck, J. Wactawski-Wende, and K. M. Perez Chen et al. Respond to "Studying the Epidemiology of Uterine Leiomyomata" by Schwartz Am. J. Epidemiol., January 1, 2001; 153(1): 30 - 30. [Full Text] [PDF]
|
|